Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-08 to 2024-01-09
Current total value of award: $5075.09
Description: 4563265850!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML